Public Health
Volume 123, Issue 9 , Pages 625-627 , September 2009

Hepatitis B vaccine uptake amongst at-risk infants: Experience from a dedicated inner city clinic

  • G. Manikkavasagan

      Affiliations

    • Haringey Teaching PCT, St Ann's Hospital, St Ann's road, London N15 3TH, UK
    • Corresponding Author InformationCorresponding author.
    • ,
  • H. El Bashir

      Affiliations

    • Haringey Teaching PCT, St Ann's Hospital, St Ann's road, London N15 3TH, UK
    • General and Adolescent Paediatric Unit, Institute of Child Health, University College London, London, UK
    • ,
  • A. Green

      Affiliations

    • Royal Free and University College Medical School, London, UK

Received 25 June 2008 ,Revised 4 June 2009 ,Accepted 20 July 2009.

References 

  1. Goudeau A, Lo KJ, Coursaget P, Tong MJ, Yeh CL, Tsai YT, et al. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunisation. Dev Biol Stand. 1983;54:399–404
  2. Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales: 1995–2000; implications for immunisation policy. J Clin Virol. 2004;29:211–220
  3. Soldan K, Gay NJ, Allain JP, Llewelyn C, Jones C, Reeeves I, et al. The prevalence of hepatitis B infection in adults with no recognised increased risk of infection. J Infect. 2000;41:198–199
  4. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolsecents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001;135:796–800
  5. Davison K, Brant L, Bukasa A, Byrne L. The NBS/HPA surveillance programme. annual report. Available from: http://www.hpa.org.uk/infections/topics_az/BIBD/publications.htm2005;[last accessed 10.03.09]
  6. Brant LJ, Hurrelle M, Balogun MA, Klapper P, Ahmad F, Boxall E, et al. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection. Epidemiol Infect. 2007;135:417–426
  7. Edmunds WJ. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies. Commun Dis Public Health. 1998;1:221–228
  8. Goldberg D, McMenamin J. The United Kingdom's hepatitis B immunisation strategy–where now?. Commun Dis Public Health. 1998;1:79–83
  9. Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994;44:144–151
  10. Sloan D, Ramsay M, Prasad L, Gelb D, Teo CG. Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. Vaccine. 2005;23:5500–5508
  11. NHS Immunisation Statistics 2004/05. Available from: http://www.ic.nhs.uk/webfiles/publications/immunisaton05/NHSImmunisation StatisticsTables220905_XLS.xls [last accessed 10.03.09].

PII: S0033-3506(09)00199-1

doi: 10.1016/j.puhe.2009.07.008

Public Health
Volume 123, Issue 9 , Pages 625-627 , September 2009

Article Tools